Teva Pharmaceutical Industries Ltd. Securities Litigation

If you purchased a significant amount of shares of Teva Pharmaceutical Industries Limited (NYSE: TEVA), you have certain options. Investors should register for updates.


Lawsuit Overview

Defendant:Teva Pharmaceutical Industries Limited
Date Filed:June 21st, 2019
Sector:Health Care
Industry:Major Pharmaceuticals
Class Start Date:August 4th, 2017
Class End Date:May 10th, 2019

According to the Complaint, Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company and the world's largest generic drug manufacturer.

The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements denying that Teva "engaged in any conduct that would give rise to liability" in various antitrust proceedings and investigations that enveloped the company; in truth, and as Defendants failed to disclose to investors, (i) contrary to its public denials, Teva had in fact engaged in a vast, industry-wide price-fixing scheme and other collusive misconduct since at least 2012; (ii) Teva was not only a participant, but the company at the heart of the anticompetitive scheme; and (iii) several Teva employees had such deep involvement in the scheme that they would ultimately be named personally as defendants in a sweeping civil enforcement action filed by the AGs of virtually every state in the nation.

Sign up for free to create a personalized portfolio with tracking and e-mail alerts for Teva Pharmaceutical Industries Limited

First Identified Complaint

Employees' Retirement System of the City of St. Petersburg, Florida, et al. v. Teva Pharmaceutical Industries Ltd., et al.

Date Filed:June 21st, 2019
Class Period Start:August 4th, 2017
Class Period End:May 10th, 2019
First Identified Complaint Filings
#Document TitleFiling Date